Bifogade filer
Flerie invites you to an investor presentation
Kurs & Likviditet
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Mid Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
June 13, 2024 - Flerie AB invites you to an investor presentation where the company will describe its investment model and portfolio strategy.
Flerie AB is an active long-term life science investor founded in 2011. The company became listed on the Nasdaq First North Growth Market through a reverse merger on June 10, 2024. Flerie intends to carry out an uplisting to the Nasdaq Stockholm (main market) with a planned first day of trading on June 27, 2024.
During the investor presentation, the company's strategy and potential will be presented. The management team will be available to answer questions from the audience on site and via webcast.
Agenda
- Flerie as a listed company – purpose and potential
Ted Fjällman, CEO - Flerie’s product development strategy explained.
Karl Elmqvist, Investment Manager - Flerie’s commercial growth strategy explained.
Mark Quick, Partner - Continuous and active value creation in the portfolio companies.
Cecilia Schéele, CFO - Time for questions
Time: June 19 at 09.00-09.45 CET. Breakfast will be served from 08.30 a.m.
Location: Inderes, Västra Trädgårdsgatan 19, Stockholm.
Webcast: Link will be provided at registration. The presentation will be made available on Flerie’s website after the event.
Registration: https://ir.financialhearings.com/flerie-investor-presentation-june-19-2024